Načítá se...
Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance
Background The majority of adverse drug reactions (ADRs) reported in the summary of product characteristics (SPCs) are based on pivotal clinical trials, performed under controlled conditions and with selected patients. Objectives (1) to observe ADRs in the real-world setting and to evaluate if the s...
Uloženo v:
| Vydáno v: | Int J Clin Pharm |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6132980/ https://ncbi.nlm.nih.gov/pubmed/29785683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11096-018-0653-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|